The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, but its legacy within the broader industry now presents questions about future yields . Alternative versions are eroding exclusivity , prompting concerns that supporting companies closely tied to Viagra's once-dominant position could be a dangerous strat